Skip to main content
. 2020 Jun 22;319(2):F178–F191. doi: 10.1152/ajprenal.00077.2020

Table 2.

Clinical characteristics of patient groups

Variables No DM
DM
Increased UAE No UAE Increased UAE No UAE
n 14 20 20 10
Age, yr 50.79 ± 9.27 54.45 ± 6.04 60.30 ± 9.33 54.78 ± 4.15
Sex (men/women), % 64.3/35.7 60.0/40.0 75.0/25.0 77.8/23.2
Systolic blood pressure, mmHg 130.79 ± 10.59 134.05 ± 18.55 143.05 ± 23.61 140.78 ± 34.06
Diastolic blood pressure, mmHg 82.50 ± 8.86 88.00 ± 13.53 82.95 ± 17.10 89.00 ± 18.04
Glucose, mg/dL 97.43 ± 17.46 103.65 ± 9.51 154.150 ± 58.49h 149.11 ± 59.53i
Glycated hemoglobin, % 5.75 ± 0.07 5.62 ± 0.21 7.15 ± 1.17g 6.47 ± 1.05i
Total cholesterol, mg/dL 204.86 ± 35.98d 184.00 ± 22.66 184.60 ± 31.14b 150.67 ± 25.18i
LDL, mg/dL 133.43 ± 30.13 116.85 ± 19.74 114.05 ± 27.92a 86.00 ± 20.58i
HDL, mg/dL 56.00 ± 13.80 51.30 ± 10.85 42.20 ± 10.68 43.67 ± 8.60
Triglycerides, mg/dL 113.86 ± 44.12 121.40 ± 57.47 244.2 ± 194.3g 159.0 ± 65.02
Plasma creatinine, mg/dL 0.91 ± 0.34 0.85 ± 0.17 1.00 ± 0.41 0.99 ± 0.27
Glomerular filtratration rate, mL·min−1·1.73 m−2 92.04 ± 29.28 89.58 ± 16.97 86.74 ± 30.23 82.81 ± 23.51
Body mass index, kg/m2 29.46 ± 5.00 30.60 ± 6.49 35.10 ± 7.57 29.51 ± 4.66
Obesity, % 42.9 40.0 65.0 44.4
Dyslipidemia, % 85.7 75.0 95.0 100
UAE-to-creatinine ratio, mg/g 221.7 ± 229.7f 4.84 ± 6.45 307.3 ± 228.8c, e 3.03 ± 1.48

Values are means ± SD. DM, diabetes mellitus; UAE, urinary albumin excretion. Comparisons between diabetic groups:

a

P < 0.05,

b

P < 0.01, and

c

P < 0.001. Comparisons between diabetic and nondiabetic groups:

d

P < 0.05,

e

P < 0.01, and

f

P < 0.001. Comparisons between increased UAE groups:

g

P < 0.05 and

h

P < 0.01. Comparisons between no UAE groups:

i

P < 0.05.